TSE:HBP's free cash flow for Q1 2024 was C$-1.84M. For the 2024 fiscal year, TSE:HBP's free cash flow was decreased by C$976.00K and operating cash flow was C$-1.83M. See a summary of the company’s cash flow.

Cash Flow	TTM	Jul 23	Jul 22	Jul 21	Jul 20	Jul 19
Operating Cash Flow	C$ -7.36M	C$ -5.53M	C$ -6.51M	C$ -9.30M	C$ -10.83M	C$ -5.54M
Investing Cash Flow	C$ -17.00K	C$ -5.00K	-	C$ 2.02M	C$ 1.70M	C$ -4.00K
Financing Cash Flow	C$ 5.77M	C$ 3.09M	C$ 6.21M	C$ 6.56M	C$ 13.10M	C$ 5.41M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	C$ 3.78M	C$ 808.00K	C$ 3.25M	C$ 3.56M	C$ 4.24M	C$ 206.00K
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	C$ 5.55M	C$ 998.00K	C$ 2.99M	C$ 3.56M	C$ 12.19M	C$ 5.41M
Issuance Of Debt	C$ -2.06M	C$ -2.06M	-	C$ 3.00M	-	-
Repayment Of Debt	C$ -2.06M	C$ -2.06M	-	C$ -158.00K	C$ -151.00K	C$ 0.00
Free Cash Flow	C$ -7.37M	C$ -5.53M	C$ -6.51M	C$ -9.30M	C$ -10.84M	C$ -5.55M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in CAD

Helix BioPharma Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing